[RVMD] YoY Quarter Result on 31-Dec-2023 [#Q4]

Stock
[RVMD] Revolution Medicines, Inc.
Announcement Date
26-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- -48.97%
YoY- -185.87%
Quarter Report
RVMD's Result
RVMD's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
Revenue 742 15,330 9,460 8,751 12,088 10,347 -40.94%
PBT -161,194 -56,630 -52,676 -33,842 -18,969 -11,339 69.99%
Tax 343 -123 -1,825 362 -4,373 363 -1.12%
NP -161,537 -56,507 -52,676 -34,204 -14,596 -11,339 70.06%
Tax Rate - - - - - - -
Total Cost 162,279 71,837 62,136 42,955 26,684 21,686 49.52%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
NP Margin -21,770.49 -368.60 -556.83 -390.86 -120.75 -109.59 187.98%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
EPS -1.14 -0.63 -0.71 -0.52 -0.40 -0.31 29.73%
EPS Diluted -1.14 -0.63 -0.71 -0.52 -0.40 -0.31 29.73%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.